Compare
Molina Healthcare, Inc. vs Humana Inc vs Centene Corp vs Elevance Health, Inc.
| Latest fiscal year | Molina Healthcare, Inc. MOH | Humana Inc HUM | Centene Corp CNC | Elevance Health, Inc. ELV |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $45.43B | $129.66B | $194.78B | $199.12B |
| Revenue growth (YoY) | +11.7% | +10.1% | +19.4% | +12.5% |
| Gross margin | n/a | n/a | 7.3% | n/a |
| Operating margin | 1.7% | 2.1% | -3.9% | 3.6% |
| Net margin | 1.0% | 0.9% | -3.4% | 2.8% |
| Net income | $472.00M | $1.19B | -$6.67B | $5.66B |
| EPS (Diluted) | $8.92 | $9.84 | -$13.53 | $25.21 |
| Operating cash flow | -$535.00M | $921.00M | $5.09B | $4.29B |
| Free cash flow | -$636.00M | $375.00M | $4.32B | $3.17B |
| Cash & equivalents | $4.25B | $4.20B | $17.89B | $9.49B |
| Total assets | $15.56B | $48.91B | $76.75B | $121.49B |
| Total liabilities | $11.49B | $31.17B | $56.69B | $77.47B |
| Shareholders' equity | $4.07B | $17.66B | $20.03B | $43.88B |
| Return on year-end equity | 11.6% | 6.7% | -33.3% | 12.9% |
| Shares outstanding | 51.00M | n/a | 491.76M | 220.72M |
Revenue, most recent five fiscal years
| Fiscal year | Molina Healthcare, Inc. | Humana Inc | Centene Corp | Elevance Health, Inc. |
|---|---|---|---|---|
| Latest | $45.43B Ended 2025-12-31 | $129.66B Ended 2025-12-31 | $194.78B Ended 2025-12-31 | $199.12B Ended 2025-12-31 |
| 1 year earlier | $40.65B Ended 2024-12-31 | $117.76B Ended 2024-12-31 | $163.07B Ended 2024-12-31 | $177.01B Ended 2024-12-31 |
| 2 years earlier | $34.07B Ended 2023-12-31 | $106.37B Ended 2023-12-31 | $154.00B Ended 2023-12-31 | $171.34B Ended 2023-12-31 |
| 3 years earlier | $31.97B Ended 2022-12-31 | $92.87B Ended 2022-12-31 | $144.55B Ended 2022-12-31 | $156.59B Ended 2022-12-31 |
| 4 years earlier | $27.77B Ended 2021-12-31 | $83.06B Ended 2021-12-31 | $125.98B Ended 2021-12-31 | $138.64B Ended 2021-12-31 |